COVID-19对欧洲DTP3疫苗接种范围的影响 (2012-2023)
Ines Aguinaga-Ontoso1,2,3, Sara Guillen-Aguinaga1,4, Laura Guillen-Aguinaga5
1Department of Health Sciences, Public University of Navarra, 31008 Pamplona, Spain.
Vaccines
|January 24, 2025
概括
COVID-19大流行影响了儿童常规免疫接种,DTP3疫苗接种率在欧洲各地有所不同. 一些国家出现下降,而另一些国家出现改善,需要量身定制的公共卫生战略.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 免疫科学 免疫科学
背景情况:
- 由于COVID-19的流行,全球儿童免疫计划受到严重破坏.
- 这种破坏威胁到几十年来控制疫苗可预防疾病的进展.
研究的目的:
- 分析COVID-19大流行对欧洲DTP3疫苗接种范围的影响.
- 为了确定疫情前后DTP3疫苗接种率的趋势和差异.
主要方法:
- 利用欧洲国家2000年至2023年的时间序列数据.
- 雇佣的结合点回归,奇平方测试和细分回归分析.
- 评估了DTP3疫苗接种趋势和覆盖范围的变化.
主要成果:
- 在欧洲各地观察到DTP3疫苗接种覆盖率的显著区域差异.
- 在爱尔兰,瑞典和瑞士等国家确定了DTP3覆盖率的减少.
- 乌克兰和圣马力诺的DTP3覆盖率有所改善.
结论:
- 流行病对DTP3疫苗接种率的影响在整个欧洲并不统一.
- 强调需要有针对性的公共卫生干预措施.
- 解决疫苗犹,后勤挑战和卫生系统不平等的问题.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.0K
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
8.6K
相关概念视频
01:51Vaccinations
43.9K
Overview
43.9K
01:30Cancer Vaccines
332
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
332